Condition: Nasopharyngeal Carcinoma · Sponsor: Sun Yat-sen University
The purpose of this study is to compare concurrent chemoradiotherapy (CCRT) alone with induction chemotherapy (gemcitabine+cisplatin) plus CCRT in patients with low-risk locoregionally advanced nasopharyngeal carcinoma(NPC).
This description comes directly from the study's public registry record.
Hai-Qiang Mai · 862087343643 · maihq@sysucc.org.cn
Always discuss trial participation with your own doctor first.
| Guangzhou Panyu Central Hospital | Guangzhou, Guangdong, China | Not Yet Recruiting |
| Sun Yat-sen University Cancer Center | Guangzhou, Guangdong, China | Recruiting |
| Zhongshan City People's Hospital | Zhongshan, Guangdong, China | Not Yet Recruiting |
| The First Affiliated Hospital of Guangxi Medical University | Nanning, Guangxi, China | Not Yet Recruiting |
| Cancer Hospital of Guizhou Province | Guiyang, Guizhou, China | Not Yet Recruiting |
| Tongji Hospital,Tongji Medical College,Huazhong University of Science and Technology | Wuhan, Hubei, China | Not Yet Recruiting |
| Union Hospital, Tongji Medical College,Huazhong University of Science and Technology; | Wuhan, Hubei, China | Not Yet Recruiting |
| Hunan Cancer Hospital | Changsha, Hunan, China | Not Yet Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05979961